Guidelines

For guidance regarding COVID-19, see FAQ by the EHA SWG on Infections

EHA creates clinical practice guidelines for diagnosis and treatment of hematologic diseases. This initiative started in 2019 with the establishment of a Guidelines Committee and the definition the EHA Methodology for guidelines. Since then, in addition to developing its own guidelines, EHA has established a framework for collaboration with ESMO (European Society for Medical Oncology) to produce guidelines on hematologic malignancies.

The Guidelines Committee has approved the following methodology documents:

For guidance regarding COVID-19, see FAQ by the EHA SWG on Infections

EHA Guidelines by topic

Guidelines produced by other societies and endorsed by EHA

Upcoming EHA Guidelines

  • Management of anti-thrombotic treatment in thrombocytopenic patients
  • Anticoagulant and anti-platelet treatment in patients with inherited bleeding disorders
  • Management of Pregnancy in Rare Inherited Anemias